Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
CytoSite Biopharma
Grant: NIH-R01CA214744
CytoSite Biopharma
Grant: K08CA249047
CytoSite Biopharma
Grant: K08CA245257
NCI NIH HHS
Grant: R01 CA214744
National Institutes of Health
Grant: 5K08CA249047-03
Enhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulation
National Institutes of Health
Grant: 5K08CA245257-04
Biomarker Identification to Increase Adjunctive Cryoablation and Checkpoint-Inhibitor Immunotherapy Response
National Institutes of Health
Grant: 5R01CA214744-04
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
Fields of Study
Keywords
Sustainable Development Goals